Bionano genomics, inc (BNGO)
Income statement / Yearly
Dec'19Dec'18Dec'17
Revenue:
Total revenue

10,129

12,000

-

Total revenue

-

-

9,505

Cost of revenue:
Total cost of revenue

6,768

8,711

6,030

Operating expenses:
Research and development

9,080

9,484

12,009

Selling, general and administrative

20,155

14,220

14,079

Impairment of property and equipment

-

-

604

Total operating expenses

29,236

23,704

26,693

Loss from operations

-25,874

-20,415

-23,218

Other income (expense)
Interest expense

2,286

1,381

590

Fair Value Adjustment of Warrants

0

-3,991

-751

Gain (Loss) on Extinguishment of Debt

-1,333

-342

-

Other expenses

299

333

289

Total other income (expenses)

-3,919

1,934

-128

Loss before income taxes

-29,794

-18,480

-23,346

Income Tax Expense (Benefit)

21

15

18

Net loss

-29,815

-18,496

-23,365

Net loss per share, basic and diluted (USD per share)

-1.99

-2.61

-8.65

Weighted-average common shares outstanding basic and diluted (shares)

14,977

7,077

2,701

Product revenue
Total revenue

9,474

11,463

-

Total revenue

-

-

8,769

Total cost of revenue

6,495

8,562

5,958

Service and other revenue
Total revenue

655

537

-

Total cost of revenue

272

149

71

Other revenue
Total revenue

-

-

735